Clinical and oncological effects of triplet chemotherapy followed by radical esophagectomy for resectable esophageal cancer associated with unfavorable prognostic factors-Reference-Cited by-同舟云学术

Clinical and oncological effects of triplet chemotherapy followed by radical esophagectomy for resectable esophageal cancer associated with unfavorable prognostic factors

Published:2013-08-21 Issue:7 Volume:44 Page:1273-1281
ISSN:0941-1291
Container-title:Surgery Today
language:en
Short-container-title:Surg Today

Author:

Shimoji Hideaki,Kinjo Tatsuya,Karimata Hiroyuki,Nagahama Masayoshi,Nishimaki Tadashi

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00595-013-0700-8.pdf

Reference20 articles.

1. Nishimaki T, Shimoji H, Sunagawa H. Recent changes and the future roles of esophageal cancer surgery. Ann Thorac Cardiovasc Surg. 2004;10:324–32.

2. Nishimaki T, Suzuki T, Suzuki S, Kuwabara S, Hatakeyama K. Outcomes of extended radical esophagectomy for thoracic esophageal cancer. J Am Coll Surg. 1998;186:306–12.

3. Nishimaki T, Suzuki T, Tanaka Y, Aizawa K, Hatakeyama K, Muto T. Intramural metastases from esophageal cancer: local indicators of advanced disease. World J Surg. 1996;20:32–7.

4. Okuyama T, Korenaga D, Edagawa A, Itoh S, Oki E, Kawanaka H, et al. Prognostic effects of oral anti-cancer drugs as adjuvant chemotherapy for 2 years after gastric cancer surgery. Surg Today. 2012;42:734–40.

5. Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ, Barbour A, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for respectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12:681–92.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Camrelizumab in combination with chemotherapy versus concurrent chemoradiotherapy for the conversion of locally advanced unresectable oesophageal squamous carcinoma: protocol for a two-arm, open-label phase II trial;BMJ Open;2024-02

2. ω-3 Fatty Acids Reduce Chemotherapy-Induced Hematological Toxicity by Bone Marrow Stimulation in Mice;Journal of Parenteral and Enteral Nutrition;2015-07-28

3. Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma;Surgery Today;2015-03-05

4. Clinicopathological factors predicting R0 resection and long-term survival after esophagectomy in patients with T4 esophageal cancer undergoing induction chemotherapy or chemoradiotherapy;Surgery Today;2014-07-25

5. Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities;World Journal of Gastrointestinal Oncology;2014